You are here

Article info

Article menu
Download PDFPDF
Inflammatory bowel disease
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease

Authors

  • A Cortot aService de Gastroenterologie, Hôpital Claude Huriez, Lille, France, bDepartment of Gastroenterology, University Hospital of Leuven, Belgium, cDepartment of Medical Gastroenterology, University Hospital of Odense, Denmark, dMedizinische Klinik II, Städtisches Krankenhaus Leverkusen, Germany, eKrankenhaus Tabea, Hamburg, Germany, fDepartment of Gastroenterology, Groote Schuur Hospital, Cape Town, South Africa, gService de Gastroentérologie, Hôpital Erasme, Bruxelles, Belgium, hClinical Research and Development, AstraZeneca R&D, Lund, Sweden PubMed articlesGoogle scholar articles
  • J-F Colombel aService de Gastroenterologie, Hôpital Claude Huriez, Lille, France, bDepartment of Gastroenterology, University Hospital of Leuven, Belgium, cDepartment of Medical Gastroenterology, University Hospital of Odense, Denmark, dMedizinische Klinik II, Städtisches Krankenhaus Leverkusen, Germany, eKrankenhaus Tabea, Hamburg, Germany, fDepartment of Gastroenterology, Groote Schuur Hospital, Cape Town, South Africa, gService de Gastroentérologie, Hôpital Erasme, Bruxelles, Belgium, hClinical Research and Development, AstraZeneca R&D, Lund, Sweden PubMed articlesGoogle scholar articles
  • P Rutgeerts aService de Gastroenterologie, Hôpital Claude Huriez, Lille, France, bDepartment of Gastroenterology, University Hospital of Leuven, Belgium, cDepartment of Medical Gastroenterology, University Hospital of Odense, Denmark, dMedizinische Klinik II, Städtisches Krankenhaus Leverkusen, Germany, eKrankenhaus Tabea, Hamburg, Germany, fDepartment of Gastroenterology, Groote Schuur Hospital, Cape Town, South Africa, gService de Gastroentérologie, Hôpital Erasme, Bruxelles, Belgium, hClinical Research and Development, AstraZeneca R&D, Lund, Sweden PubMed articlesGoogle scholar articles
  • K Lauritsen aService de Gastroenterologie, Hôpital Claude Huriez, Lille, France, bDepartment of Gastroenterology, University Hospital of Leuven, Belgium, cDepartment of Medical Gastroenterology, University Hospital of Odense, Denmark, dMedizinische Klinik II, Städtisches Krankenhaus Leverkusen, Germany, eKrankenhaus Tabea, Hamburg, Germany, fDepartment of Gastroenterology, Groote Schuur Hospital, Cape Town, South Africa, gService de Gastroentérologie, Hôpital Erasme, Bruxelles, Belgium, hClinical Research and Development, AstraZeneca R&D, Lund, Sweden PubMed articlesGoogle scholar articles
  • H Malchow aService de Gastroenterologie, Hôpital Claude Huriez, Lille, France, bDepartment of Gastroenterology, University Hospital of Leuven, Belgium, cDepartment of Medical Gastroenterology, University Hospital of Odense, Denmark, dMedizinische Klinik II, Städtisches Krankenhaus Leverkusen, Germany, eKrankenhaus Tabea, Hamburg, Germany, fDepartment of Gastroenterology, Groote Schuur Hospital, Cape Town, South Africa, gService de Gastroentérologie, Hôpital Erasme, Bruxelles, Belgium, hClinical Research and Development, AstraZeneca R&D, Lund, Sweden PubMed articlesGoogle scholar articles
  • J Hämling aService de Gastroenterologie, Hôpital Claude Huriez, Lille, France, bDepartment of Gastroenterology, University Hospital of Leuven, Belgium, cDepartment of Medical Gastroenterology, University Hospital of Odense, Denmark, dMedizinische Klinik II, Städtisches Krankenhaus Leverkusen, Germany, eKrankenhaus Tabea, Hamburg, Germany, fDepartment of Gastroenterology, Groote Schuur Hospital, Cape Town, South Africa, gService de Gastroentérologie, Hôpital Erasme, Bruxelles, Belgium, hClinical Research and Development, AstraZeneca R&D, Lund, Sweden PubMed articlesGoogle scholar articles
  • T Winter aService de Gastroenterologie, Hôpital Claude Huriez, Lille, France, bDepartment of Gastroenterology, University Hospital of Leuven, Belgium, cDepartment of Medical Gastroenterology, University Hospital of Odense, Denmark, dMedizinische Klinik II, Städtisches Krankenhaus Leverkusen, Germany, eKrankenhaus Tabea, Hamburg, Germany, fDepartment of Gastroenterology, Groote Schuur Hospital, Cape Town, South Africa, gService de Gastroentérologie, Hôpital Erasme, Bruxelles, Belgium, hClinical Research and Development, AstraZeneca R&D, Lund, Sweden PubMed articlesGoogle scholar articles
  • A Van Gossum aService de Gastroenterologie, Hôpital Claude Huriez, Lille, France, bDepartment of Gastroenterology, University Hospital of Leuven, Belgium, cDepartment of Medical Gastroenterology, University Hospital of Odense, Denmark, dMedizinische Klinik II, Städtisches Krankenhaus Leverkusen, Germany, eKrankenhaus Tabea, Hamburg, Germany, fDepartment of Gastroenterology, Groote Schuur Hospital, Cape Town, South Africa, gService de Gastroentérologie, Hôpital Erasme, Bruxelles, Belgium, hClinical Research and Development, AstraZeneca R&D, Lund, Sweden PubMed articlesGoogle scholar articles
  • T Persson aService de Gastroenterologie, Hôpital Claude Huriez, Lille, France, bDepartment of Gastroenterology, University Hospital of Leuven, Belgium, cDepartment of Medical Gastroenterology, University Hospital of Odense, Denmark, dMedizinische Klinik II, Städtisches Krankenhaus Leverkusen, Germany, eKrankenhaus Tabea, Hamburg, Germany, fDepartment of Gastroenterology, Groote Schuur Hospital, Cape Town, South Africa, gService de Gastroentérologie, Hôpital Erasme, Bruxelles, Belgium, hClinical Research and Development, AstraZeneca R&D, Lund, Sweden PubMed articlesGoogle scholar articles
  • E Pettersson aService de Gastroenterologie, Hôpital Claude Huriez, Lille, France, bDepartment of Gastroenterology, University Hospital of Leuven, Belgium, cDepartment of Medical Gastroenterology, University Hospital of Odense, Denmark, dMedizinische Klinik II, Städtisches Krankenhaus Leverkusen, Germany, eKrankenhaus Tabea, Hamburg, Germany, fDepartment of Gastroenterology, Groote Schuur Hospital, Cape Town, South Africa, gService de Gastroentérologie, Hôpital Erasme, Bruxelles, Belgium, hClinical Research and Development, AstraZeneca R&D, Lund, Sweden PubMed articlesGoogle scholar articles
  1. A Cortot, Service de Gastroenterologie, Hôpital Claude Huriez F-59037 Lille, France.a-cortot{at}chru-lille.fr
View Full Text

Citation

Cortot A, Colombel J, Rutgeerts P for the International Budesonide Study Group, et al
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease
Gut 2001;48:186-190.

Publication history

  • Accepted August 8, 2000
  • First published February 1, 2001.
Online issue publication 
January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

British Society of Gastroenterology